Thanks Leo. The simple way to view is there is risk here, there is potential reward here. I believe beyond doubt that chemosat is very good for at least probably 10 percent of OM candidates, and somewhat good for others. An expensive long scientifically overpowering trial is not all bad. There is much more room for commercial optimism if there is at least 100 patients in a controlled setting fully tested where 50 percent is bac. That 6 treatments max per patient will always make me a partial Simpson fan, no matter whether everything goes south
Leo, That is probably the most selfless and logical post that I've ever read on this board. People get so caught up on their egos and either hyping or criticising everyone else and the decisions they've made, purely for a financial gain. It is refreshing to see someone reel it back in to what this is truly all about - improving lives. Thank you for letting the genuinity come through. Cheers!